{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:07:35Z","timestamp":1790701655701,"version":"4.1.0"},"reference-count":209,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/mt.2015.194","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T11:20:55Z","timestamp":1445253655000},"page":"6-16","source":"Crossref","is-referenced-by-count":101,"title":["Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5\u2013based Constructs"],"prefix":"10.1016","volume":"24","author":[{"given":"Julio","family":"Alonso-Padilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u0151z\u0151 L","family":"Kaj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Benk\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menzo","family":"Havenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Lemckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Harrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.194_bib1","series-title":"Virus Taxonomy","first-page":"pp. 125","author":"Harrach","year":"2011"},{"key":"10.1038\/mt.2015.194_bib2","unstructured":"B. Harrach http:\/\/www.vmri.hu\/~harrach\/ADENOSEQ.HTM Accessed 1 September 2015"},{"key":"10.1038\/mt.2015.194_bib3","first-page":"pp. 24","volume":"vol. 1.","author":"Benk\u0151","year":"2008","journal-title":"Adenoviruses: pathogenesis. Encyclopedia of Virology"},{"key":"10.1038\/mt.2015.194_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1126\/science.1187433","article-title":"Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks","volume":"329","author":"Liu","year":"2010","journal-title":"Science"},{"key":"10.1038\/mt.2015.194_bib5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1126\/science.1187292","article-title":"Crystal structure of human adenovirus at 3.5 A resolution","volume":"329","author":"Reddy","year":"2010","journal-title":"Science"},{"key":"10.1038\/mt.2015.194_bib6","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.1074\/jbc.M113.537498","article-title":"Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomics","volume":"289","author":"Benevento","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2015.194_bib7","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.1408462111","article-title":"Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection","volume":"111","author":"Reddy","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.194_bib8","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods","volume":"77","author":"Rux","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.2015.194_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1083\/jcb.127.1.257","article-title":"Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization","volume":"127","author":"Wickham","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2015.194_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cmi.12053","article-title":"Adenovirus signalling in entry","volume":"15","author":"Wolfrum","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.1038\/mt.2015.194_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1038\/mt.2015.194_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chom.2011.07.006","article-title":"Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure","volume":"10","author":"Burckhardt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1038\/mt.2015.194_bib14","author":"Vectors used in gene therapy clinical trials.","year":"2015","journal-title":"The Journal of Gene Medicine"},{"key":"10.1038\/mt.2015.194_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2015.194_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nbt0104-3","article-title":"China approves first gene therapy","volume":"22","author":"Pearson","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2015.194_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2008.12.016","article-title":"Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency","volume":"96","author":"Wilson","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2015.194_bib18","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1096\/fj.12-224659","article-title":"Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors","volume":"27","author":"Chorny","year":"2013","journal-title":"FASEB J"},{"key":"10.1038\/mt.2015.194_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib20","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1161\/CIRCULATIONAHA.110.012732","article-title":"Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy","volume":"124","author":"George","year":"2011","journal-title":"Circulation"},{"key":"10.1038\/mt.2015.194_bib21","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/v2102196","article-title":"Serotype chimeric human adenoviruses for cancer gene therapy","volume":"2","author":"Ranki","year":"2010","journal-title":"Viruses"},{"key":"10.1038\/mt.2015.194_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib23","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1073\/pnas.94.6.2587","article-title":"Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression","volume":"94","author":"Ilan","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.194_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2010.12.054","article-title":"Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors","volume":"412","author":"Schaack","year":"2011","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fimmu.2011.00040","article-title":"Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm","volume":"2","author":"Aldhamen","year":"2011","journal-title":"Front Immunol"},{"key":"10.1038\/mt.2015.194_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/pharmaceutics3030338","article-title":"Adenovirus vector-derived VA-RNA-mediated innate immune responses","volume":"3","author":"Machitani","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1038\/mt.2015.194_bib27","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.194_bib28","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1128\/JVI.00123-12","article-title":"The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes","volume":"86","author":"Perreau","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib29","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/JVI.02160-10","article-title":"Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway","volume":"85","author":"Minamitani","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156652311796150363","article-title":"Advances and future challenges in adenoviral vector pharmacology and targeting","volume":"11","author":"Khare","year":"2011","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2015.194_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymthe.2006.01.003","article-title":"Adenovirus type 5 interactions with human blood cells may compromise systemic delivery","volume":"14","author":"Lyons","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2015.194_bib33","doi-asserted-by":"crossref","first-page":"e1000277","DOI":"10.1371\/journal.ppat.1000277","article-title":"The cell adhesion molecule \u201cCAR\u201d and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution","volume":"5","author":"Seiradake","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2015.194_bib34","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib35","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.01392-12","article-title":"Circulating antibodies and macrophages as modulators of adenovirus pharmacology","volume":"87","author":"Khare","year":"2013","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib36","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1128\/JVI.03217-14","article-title":"Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors","volume":"89","author":"Qiu","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1038\/mt.2015.194_bib38","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1073\/pnas.0711757105","article-title":"Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo","volume":"105","author":"Kalyuzhniy","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.194_bib39","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/mt.2008.132","article-title":"Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver","volume":"16","author":"Vigant","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2015.194_bib41","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1128\/JVI.02562-08","article-title":"Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells","volume":"83","author":"Jonsson","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib42","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1128\/JVI.06088-11","article-title":"Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells","volume":"85","author":"Lenman","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.1226625","article-title":"Coagulation factor X activates innate immunity to human species C adenovirus","volume":"338","author":"Doronin","year":"2012","journal-title":"Science"},{"key":"10.1038\/mt.2015.194_bib44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Xu","year":"2013","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.194_bib45","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/JVI.03576-14","article-title":"Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes","volume":"89","author":"Eichholz","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib46","doi-asserted-by":"crossref","first-page":"e1002281","DOI":"10.1371\/journal.ppat.1002281","article-title":"Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium","volume":"7","author":"Ganesan","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2015.194_bib47","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mt.2012.287","article-title":"SR-A and SREC-I are Kupffer and endothelial cell receptors for helper-dependent adenoviral vectors","volume":"21","author":"Piccolo","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib49","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/mt.sj.6300119","article-title":"Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy","volume":"15","author":"Mocanu","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/gt.2014.71","article-title":"SR-A and SREC-I binding peptides increase HDAd-mediated liver transduction","volume":"21","author":"Piccolo","year":"2014","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib51","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/mt.2011.71","article-title":"Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer","volume":"19","author":"Khare","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib52","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/mt.2014.80","article-title":"Ad5\/48 hexon oncolytic virus expressing sTGF\u03b2RIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases","volume":"22","author":"Xu","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib53","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib54","doi-asserted-by":"crossref","first-page":"E3503","DOI":"10.1073\/pnas.1208972109","article-title":"Merck Ad5\/HIV induces broad innate immune activation that predicts CD8 T-cell responses but is attenuated by preexisting Ad5 immunity","volume":"109","author":"Zak","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.194_bib55","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jmv.23546","article-title":"Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults","volume":"85","author":"Zhang","year":"2013","journal-title":"J Med Virol"},{"key":"10.1038\/mt.2015.194_bib56","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mt.2015.194_bib59","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/JVI.70.4.2116-2123.1996","article-title":"Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes","volume":"70","author":"Gall","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib60","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1038\/mt.2015.194_bib61","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.194_bib62","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1128\/JVI.73.7.6056-6065.1999","article-title":"Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors","volume":"73","author":"Miyazawa","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib63","doi-asserted-by":"crossref","first-page":"10354","DOI":"10.1128\/JVI.00936-14","article-title":"Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity","volume":"88","author":"Teigler","year":"2014","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib64","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1089\/hum.1998.9.10-1419","article-title":"Extensive cross-reactivity of adenovirus-specific cytotoxic T cells","volume":"9","author":"Smith","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib65","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1128\/JVI.74.16.7678-7682.2000","article-title":"Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes","volume":"74","author":"Molinier-Frenkel","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib66","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/JVI.77.11.6562-6566.2003","article-title":"Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy","volume":"77","author":"Heemskerk","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib67","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2009.10.091","article-title":"Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive","volume":"28","author":"Hutnick","year":"2010","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib68","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.virol.2006.01.024","article-title":"Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins","volume":"350","author":"Tang","year":"2006","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib69","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/104303402320138952","article-title":"The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope","volume":"13","author":"Olive","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib70","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells","volume":"104","author":"Leen","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2015.194_bib71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1099\/vir.0.002493-0","article-title":"Adenovirus DNA polymerase is recognized by human CD8+ T cells","volume":"90","author":"Joshi","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/cgt.2009.17","article-title":"Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity","volume":"16","author":"Osada","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.194_bib73","doi-asserted-by":"crossref","first-page":"14595","DOI":"10.1128\/JVI.79.23.14595-14605.2005","article-title":"Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus","volume":"79","author":"Perreau","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib74","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/v2092013","article-title":"Improving adenovirus based gene transfer: strategies to accomplish immune evasion","volume":"2","author":"Seregin","year":"2010","journal-title":"Viruses"},{"key":"10.1038\/mt.2015.194_bib75","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2008.297","article-title":"Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy","volume":"17","author":"Seregin","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib76","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/mt.2009.312","article-title":"Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates","volume":"18","author":"Fontanellas","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mt.6300031","article-title":"Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors","volume":"15","author":"Cerullo","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib79","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood-2010-03-276949","article-title":"Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo","volume":"116","author":"Seregin","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2015.194_bib80","doi-asserted-by":"crossref","first-page":"e3089","DOI":"10.1371\/journal.pntd.0003089","article-title":"Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection","volume":"8","author":"Farrow","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1038\/mt.2015.194_bib81","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/IAI.74.2.1009-1015.2006","article-title":"Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4","volume":"74","author":"McConnell","year":"2006","journal-title":"Infect Immun"},{"key":"10.1038\/mt.2015.194_bib82","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1128\/JVI.76.17.8621-8631.2002","article-title":"Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein","volume":"76","author":"Belousova","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib83","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/14712590903307388","article-title":"Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors","volume":"9","author":"Seregin","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2015.194_bib84","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v6020832","article-title":"The evolution of adenoviral vectors through genetic and chemical surface modifications","volume":"6","author":"Capasso","year":"2014","journal-title":"Viruses"},{"key":"10.1038\/mt.2015.194_bib85","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.gt.3302295","article-title":"Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus","volume":"11","author":"Green","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib86","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/hum.2009.028","article-title":"Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus","volume":"20","author":"Doronin","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.mt.6300321","article-title":"Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide","volume":"16","author":"Kreppel","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib88","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.biomaterials.2012.02.011","article-title":"A hexon-specific PEGylated adenovirus vector utilizing blood coagulation factor X","volume":"33","author":"Matsui","year":"2012","journal-title":"Biomaterials"},{"key":"10.1038\/mt.2015.194_bib89","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.biomaterials.2010.10.060","article-title":"Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction","volume":"32","author":"Suzuki-Kouyama","year":"2011","journal-title":"Biomaterials"},{"key":"10.1038\/mt.2015.194_bib90","doi-asserted-by":"crossref","first-page":"e82716","DOI":"10.1371\/journal.pone.0082716","article-title":"Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo","volume":"9","author":"Prill","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib91","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"Krasnykh","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib92","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1128\/JVI.73.10.8689-8695.1999","article-title":"A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia","volume":"73","author":"Zabner","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib93","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1128\/JVI.75.7.3335-3342.2001","article-title":"Improved adenovirus vectors for infection of cardiovascular tissues","volume":"75","author":"Havenga","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib94","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/JVI.80.6.2747-2759.2006","article-title":"Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers","volume":"80","author":"Lecollinet","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib95","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"10.1038\/mt.2015.194_bib96","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/hum.2009.056","article-title":"Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia","volume":"21","author":"Granio","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib97","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/gt.2013.44","article-title":"Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction","volume":"20","author":"Parker","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib98","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2012.003","article-title":"Capsid-modified adenoviral vectors for improved muscle-directed gene therapy","volume":"23","author":"Guse","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib99","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/104303403322542248","article-title":"Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates","volume":"14","author":"Smith","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ymthe.2004.05.020","article-title":"Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats","volume":"10","author":"Nicol","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib101","doi-asserted-by":"crossref","first-page":"e33920","DOI":"10.1371\/journal.pone.0033920","article-title":"Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses","volume":"7","author":"Bruder","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib102","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1128\/JVI.00462-13","article-title":"Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors","volume":"87","author":"Bruder","year":"2013","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib103","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/infdis\/jiu217","article-title":"First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)","volume":"210","author":"Baden","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2015.194_bib104","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib105","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1093\/nar\/gkv031","article-title":"Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses","volume":"43","author":"M\u00fcck-H\u00e4usl","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2015.194_bib106","doi-asserted-by":"crossref","first-page":"e1004090","DOI":"10.1371\/journal.ppat.1004090","article-title":"High-efficiency targeted editing of large viral genomes by RNA-guided nucleases","volume":"10","author":"Bi","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2015.194_bib107","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib108","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/JVI.02950-14","article-title":"Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors","volume":"89","author":"Abbink","year":"2015","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/hum.1996.7.1-79","article-title":"\u201cSero-switch\u201d adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype","volume":"7","author":"Mastrangeli","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib110","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1128\/JVI.71.11.8946-8951.1997","article-title":"Construction of an adenovirus type 7a E1A- vector","volume":"71","author":"Abrahamsen","year":"1997","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib111","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.70.9.6497-6501.1996","article-title":"A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4","volume":"70","author":"Brough","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib112","first-page":"423","article-title":"New serotypes of adenoviral vectors","volume":"8","author":"Stone","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2015.194_bib113","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2005.08.024","article-title":"The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3","volume":"343","author":"Sirena","year":"2005","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib114","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/JVI.79.8.5090-5104.2005","article-title":"Development and assessment of human adenovirus type 11 as a gene transfer vector","volume":"79","author":"Stone","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0042-6822(03)00161-2","article-title":"Development of adenovirus serotype 35 as a gene transfer vector","volume":"311","author":"Seshidhar Reddy","year":"2003","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib116","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/mt.2012.115","article-title":"Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer","volume":"20","author":"Hemminki","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib117","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.4161\/hv.26038","article-title":"Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults","volume":"9","author":"Creech","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1038\/mt.2015.194_bib118","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/vir.0.83119-0","article-title":"High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector","volume":"88","author":"Vogels","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib119","doi-asserted-by":"crossref","first-page":"e2409","DOI":"10.1371\/journal.pone.0002409","article-title":"Directed evolution generates a novel oncolytic virus for the treatment of colon cancer","volume":"3","author":"Kuhn","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/gt.2014.2","article-title":"Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood","volume":"21","author":"Di","year":"2014","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib121","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1099\/vir.0.81956-0","article-title":"Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells","volume":"87","author":"Havenga","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib122","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.vaccine.2010.06.050","article-title":"Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28","volume":"28","author":"Kahl","year":"2010","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib123","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib124","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1099\/vir.0.82079-0","article-title":"Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity","volume":"87","author":"Lemckert","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib125","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","author":"Teigler","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib126","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.vaccine.2015.03.070","article-title":"A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants","volume":"33","author":"Tameris","year":"2015","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib127","doi-asserted-by":"crossref","first-page":"e78679","DOI":"10.1371\/journal.pone.0078679","article-title":"A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age","volume":"8","author":"Ou\u00e9draogo","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib128","doi-asserted-by":"crossref","first-page":"e41936","DOI":"10.1371\/journal.pone.0041936","article-title":"A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults","volume":"7","author":"Keefer","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/infdis\/jis670","article-title":"First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)","volume":"207","author":"Baden","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2015.194_bib130","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1586\/14760584.2015.1077122","article-title":"Adenovirus-vectored Ebola vaccines","volume":"14","author":"Gilbert","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1038\/mt.2015.194_bib131","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/jiu485","article-title":"Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans","volume":"211","author":"Baden","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2015.194_bib132","doi-asserted-by":"crossref","first-page":"e44115","DOI":"10.1371\/journal.pone.0044115","article-title":"Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species","volume":"7","author":"Zahn","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib133","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.vaccine.2013.11.055","article-title":"Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression","volume":"32","author":"Johnson","year":"2014","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib134","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2015.019","article-title":"Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector","volume":"26","author":"Dakin","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib135","doi-asserted-by":"crossref","first-page":"e31177","DOI":"10.1371\/journal.pone.0031177","article-title":"Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin","volume":"7","author":"Alexander","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib136","doi-asserted-by":"crossref","first-page":"e82380","DOI":"10.1371\/journal.pone.0082380","article-title":"Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C","volume":"8","author":"Alexander","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib137","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1038\/mt.2015.194_bib138","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.vaccine.2006.11.025","article-title":"Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41","volume":"25","author":"Lemiale","year":"2007","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib139","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.30.10.2733-2734.1992","article-title":"Seroprevalence of enteric and nonenteric adenoviruses in Bangladesh","volume":"30","author":"Jarecki-Khan","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1038\/mt.2015.194_bib140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1386-6532(99)00071-2","article-title":"Antibodies to enteric adenoviruses (Ad40 and Ad41) in sera from Iranian children","volume":"16","author":"Saderi","year":"2000","journal-title":"J Clin Virol"},{"key":"10.1038\/mt.2015.194_bib141","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.01811-08","article-title":"Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors","volume":"83","author":"Ko","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib142","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2005.08.101","article-title":"Development of nonhuman adenoviruses as vaccine vectors","volume":"24","author":"Bangari","year":"2006","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib143","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.vaccine.2014.11.055","article-title":"Bovine adenovirus-3 as a vaccine delivery vehicle","volume":"33","author":"Ayalew","year":"2015","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib144","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0264-410X(99)00347-3","article-title":"Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever","volume":"18","author":"Hammond","year":"2000","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1099\/0022-1317-82-1-183","article-title":"Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene","volume":"82","author":"Tuboly","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib146","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(02)00344-4","article-title":"Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge","volume":"20","author":"Fischer","year":"2002","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib147","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.micinf.2005.11.007","article-title":"Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein","volume":"8","author":"Hu","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1038\/mt.2015.194_bib148","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/03079457.2010.507239","article-title":"Antibody fragments, expressed by a fowl adenovirus vector, are able to neutralize infectious bursal disease virus","volume":"39","author":"Greenall","year":"2010","journal-title":"Avian Pathol"},{"key":"10.1038\/mt.2015.194_bib149","first-page":"123","article-title":"Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing","volume":"134","author":"Brake","year":"2012","journal-title":"Dev Biol (Basel)"},{"key":"10.1038\/mt.2015.194_bib150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2013.228","article-title":"Circumventing antivector immunity: potential use of nonhuman adenoviral vectors","volume":"25","author":"Lopez-Gordo","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib151","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1002\/jgm.497","article-title":"CAR chasing: canine adenovirus vectors-all bite and no bark?","volume":"6","author":"Kremer","year":"2004","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2015.194_bib152","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1096\/fj.01-0321fje","article-title":"Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo","volume":"15","author":"Soudais","year":"2001","journal-title":"FASEB J"},{"key":"10.1038\/mt.2015.194_bib153","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1096\/fj.03-0438fje","article-title":"Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors","volume":"18","author":"Soudais","year":"2004","journal-title":"FASEB J"},{"key":"10.1038\/mt.2015.194_bib154","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-679-5_13","article-title":"Scalable production of adenovirus vectors","volume":"1089","author":"Silva","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2015.194_bib155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-62703-679-5_14","article-title":"Canine adenovirus downstream processing protocol","volume":"1089","author":"Puig","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2015.194_bib156","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1038\/srep09135","article-title":"Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation","volume":"5","author":"Fernandes","year":"2015","journal-title":"Sci Rep"},{"key":"10.1038\/mt.2015.194_bib157","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virusres.2011.09.031","article-title":"Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer","volume":"163","author":"Tandon","year":"2012","journal-title":"Virus Res"},{"key":"10.1038\/mt.2015.194_bib158","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bbrc.2004.12.099","article-title":"Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture","volume":"327","author":"Bangari","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2015.194_bib159","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.gt.3300949","article-title":"Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid","volume":"6","author":"Nguyen","year":"1999","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jgm.1283","article-title":"Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting","volume":"11","author":"Lenaerts","year":"2009","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2015.194_bib161","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1128\/JVI.72.8.6325-6331.1998","article-title":"Mouse adenovirus type 1 early region 1A is dispensable for growth in cultured fibroblasts","volume":"72","author":"Ying","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib162","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/viro.2002.1389","article-title":"Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines","volume":"295","author":"van Olphen","year":"2002","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib163","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0042-6822(03)00286-1","article-title":"A recombinant E1-deleted porcine adenovirus-3 as an expression vector","volume":"313","author":"Zakhartchouk","year":"2003","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib164","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1128\/JVI.73.10.8640-8646.1999","article-title":"In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 null mutant","volume":"73","author":"Cauthen","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1099\/0022-1317-80-3-563","article-title":"Development of porcine adenovirus-3 as an expression vector","volume":"80","author":"Reddy","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib166","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1128\/JVI.73.11.9137-9144.1999","article-title":"Replication-defective bovine adenovirus type 3 as an expression vector","volume":"73","author":"Reddy","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib167","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.virol.2009.06.029","article-title":"Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry","volume":"392","author":"Li","year":"2009","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib168","doi-asserted-by":"crossref","first-page":"e31454","DOI":"10.1371\/journal.pone.0031454","article-title":"Interaction between mouse adenovirus type 1 and cell surface heparan sulfate proteoglycans","volume":"7","author":"Lenaerts","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.194_bib169","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virusres.2010.07.021","article-title":"Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model","volume":"153","author":"Sharma","year":"2010","journal-title":"Virus Res"},{"key":"10.1038\/mt.2015.194_bib170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/gt.2010.1","article-title":"Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses","volume":"17","author":"Sharma","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib171","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgm.1530","article-title":"Creation of a panel of vectors based on ape adenovirus isolates","volume":"13","author":"Roy","year":"2011","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2015.194_bib172","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/0022-1317-83-1-151","article-title":"Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor","volume":"83","author":"Cohen","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib173","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa","volume":"12","author":"Xiang","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1038\/mt.2015.194_bib174","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.194_bib175","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.75.23.11603-11613.2001","article-title":"Replication-defective vector based on a chimpanzee adenovirus","volume":"75","author":"Farina","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib176","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/10430340460745838","article-title":"Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors","volume":"15","author":"Roy","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.194_bib177","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.194_bib178","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.194_bib179","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jir850","article-title":"Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector","volume":"205","author":"O'Hara","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2015.194_bib180","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.194_bib181","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.194_bib182","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1099\/0022-1317-82-6-1465","article-title":"Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins","volume":"82","author":"Tan","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib183","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1128\/JVI.73.2.1399-1410.1999","article-title":"Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors","volume":"73","author":"Michou","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib184","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0264-410X(03)00544-9","article-title":"Antibody response and virus tissue distribution in chickens inoculated with wild-type and recombinant fowl adenoviruses","volume":"22","author":"Ojkic","year":"2003","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s007050050309","article-title":"The major late promoter and bipartite leader sequence of fowl adenovirus","volume":"143","author":"Sheppard","year":"1998","journal-title":"Arch Virol"},{"key":"10.1038\/mt.2015.194_bib186","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virusres.2010.01.014","article-title":"The non-essential left end region of the fowl adenovirus 9 genome is suitable for foreign gene insertion\/replacement","volume":"149","author":"Corredor","year":"2010","journal-title":"Virus Res"},{"key":"10.1038\/mt.2015.194_bib187","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virusres.2003.11.018","article-title":"Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo","volume":"100","author":"Cherenova","year":"2004","journal-title":"Virus Res"},{"key":"10.1038\/mt.2015.194_bib188","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.cgt.7700822","article-title":"Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors","volume":"12","author":"Shashkova","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.194_bib189","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.gt.3302146","article-title":"Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53","volume":"11","author":"Logunov","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.194_bib190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.0818-9641.2004.01223.x","article-title":"Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector","volume":"82","author":"Both","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1038\/mt.2015.194_bib191","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/viro.1997.8452","article-title":"Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences","volume":"230","author":"Xu","year":"1997","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib192","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/viro.1997.8861","article-title":"Gene expression by atypical recombinant ovine adenovirus vectors during abortive infection of human and animal cells in vitro","volume":"239","author":"Khatri","year":"1997","journal-title":"Virology"},{"key":"10.1038\/mt.2015.194_bib193","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1128\/JVI.73.8.6930-6936.1999","article-title":"Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo","volume":"73","author":"Hofmann","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib194","doi-asserted-by":"crossref","first-page":"11941","DOI":"10.1128\/JVI.77.22.11941-11951.2003","article-title":"Construction, rescue, and characterization of vectors derived from ovine atadenovirus","volume":"77","author":"L\u00f6ser","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib195","first-page":"69","article-title":"Production and release testing of ovine atadenovirus vectors","volume":"130","author":"Both","year":"2007","journal-title":"Methods Mol Med"},{"key":"10.1038\/mt.2015.194_bib196","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jgm.474","article-title":"Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease","volume":"6","author":"Martiniello-Wilks","year":"2004","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2015.194_bib197","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CJI.0b013e318238a115","article-title":"Potent antietumor immunity in mice induced by vaccination with an ovine atadenovirus vector","volume":"35","author":"Tang","year":"2012","journal-title":"J Immunother"},{"key":"10.1038\/mt.2015.194_bib198","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/CVI.00291-10","article-title":"Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus","volume":"17","author":"Fraser","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1038\/mt.2015.194_bib199","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.vaccine.2009.09.136","article-title":"Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine","volume":"28","author":"Bridgeman","year":"2009","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.194_bib200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.meegid.2013.03.049","article-title":"Partial characterization of a new adenovirus lineage discovered in testudinoid turtles","volume":"17","author":"Doszpoly","year":"2013","journal-title":"Infect Genet Evol"},{"key":"10.1038\/mt.2015.194_bib201","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.meegid.2015.01.024","article-title":"Phylogenomic characterization of California sea lion adenovirus-1","volume":"31","author":"Cort\u00e9s-Hinojosa","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1038\/mt.2015.194_bib202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-0934(87)90001-2","article-title":"Pitfalls in the identification of adenoviruses","volume":"16","author":"Wigand","year":"1987","journal-title":"J Virol Methods"},{"key":"10.1038\/mt.2015.194_bib203","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.32.9.2321-2323.1994","article-title":"Genome analysis of South American adenovirus strains of serotype 7 collected over a 7-year period","volume":"32","author":"Kajon","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1038\/mt.2015.194_bib204","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2307\/1592167","article-title":"Characterization of an avian adenovirus associated with inclusion body hepatitis in day-old turkeys","volume":"41","author":"Guy","year":"1997","journal-title":"Avian Dis"},{"key":"10.1038\/mt.2015.194_bib205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1099\/0022-1317-71-2-465","article-title":"Molecular cloning and physical mapping of the DNA of bovine adenovirus serotype 4; study of the DNA homology among bovine, human and porcine adenoviruses","volume":"71","author":"Benk\u00f6","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2015.194_bib206","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00705-005-0722-7","article-title":"Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene","volume":"151","author":"Lu","year":"2006","journal-title":"Arch Virol"},{"key":"10.1038\/mt.2015.194_bib207","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jviromet.2012.04.005","article-title":"Real-time PCR assay for universal detection and quantitation of all five species of fowl adenoviruses (FAdV-A to FAdV-E)","volume":"183","author":"G\u00fcnes","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1038\/mt.2015.194_bib208","doi-asserted-by":"crossref","first-page":"13366","DOI":"10.1128\/JVI.78.23.13366-13369.2004","article-title":"Detection and analysis of six lizard adenoviruses by consensus primer PCR provides further evidence of a reptilian origin for the atadenoviruses","volume":"78","author":"Wellehan","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.194_bib209","doi-asserted-by":"crossref","first-page":"e72787","DOI":"10.1371\/journal.pone.0072787","article-title":"The viruses of wild pigeon droppings","volume":"8","author":"Phan","year":"2013","journal-title":"PLoS One"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T23:43:26Z","timestamp":1599695006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616303021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":209,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1525001616303021"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.194","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}